全文获取类型
收费全文 | 54103篇 |
免费 | 5218篇 |
国内免费 | 2593篇 |
专业分类
耳鼻咽喉 | 909篇 |
儿科学 | 1166篇 |
妇产科学 | 350篇 |
基础医学 | 7542篇 |
口腔科学 | 8230篇 |
临床医学 | 4477篇 |
内科学 | 5319篇 |
皮肤病学 | 561篇 |
神经病学 | 1721篇 |
特种医学 | 2324篇 |
外国民族医学 | 24篇 |
外科学 | 10590篇 |
综合类 | 8106篇 |
现状与发展 | 8篇 |
预防医学 | 1665篇 |
眼科学 | 603篇 |
药学 | 3292篇 |
26篇 | |
中国医学 | 1852篇 |
肿瘤学 | 3149篇 |
出版年
2024年 | 93篇 |
2023年 | 771篇 |
2022年 | 1292篇 |
2021年 | 2034篇 |
2020年 | 2056篇 |
2019年 | 1852篇 |
2018年 | 1753篇 |
2017年 | 1864篇 |
2016年 | 1842篇 |
2015年 | 2167篇 |
2014年 | 3386篇 |
2013年 | 4687篇 |
2012年 | 2902篇 |
2011年 | 3437篇 |
2010年 | 2991篇 |
2009年 | 2834篇 |
2008年 | 2801篇 |
2007年 | 2797篇 |
2006年 | 2547篇 |
2005年 | 2375篇 |
2004年 | 2142篇 |
2003年 | 1889篇 |
2002年 | 1535篇 |
2001年 | 1321篇 |
2000年 | 1052篇 |
1999年 | 964篇 |
1998年 | 811篇 |
1997年 | 770篇 |
1996年 | 714篇 |
1995年 | 517篇 |
1994年 | 514篇 |
1993年 | 383篇 |
1992年 | 372篇 |
1991年 | 304篇 |
1990年 | 257篇 |
1989年 | 238篇 |
1988年 | 193篇 |
1987年 | 154篇 |
1986年 | 138篇 |
1985年 | 180篇 |
1984年 | 140篇 |
1983年 | 114篇 |
1982年 | 132篇 |
1981年 | 96篇 |
1980年 | 94篇 |
1979年 | 91篇 |
1978年 | 98篇 |
1977年 | 65篇 |
1976年 | 62篇 |
1975年 | 37篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
11.
12.
2型糖尿病及骨质疏松已成为我国最主要的慢性代谢性疾病。2型糖尿病常伴有血脂紊乱,常表现为低密度脂蛋白升高,而越来越多的研究表明血脂通过不同的方式影响骨代谢,其机制可能是通过抑制骨髓间充质干细胞成骨分化,通过RANK/RNAKL/OPG信号通路及炎症反应调节破骨细胞等方式调节骨代谢。 相似文献
13.
《European journal of surgical oncology》2019,45(10):1812-1816
ObjectivesMeshes/matrices are commonly used in immediate breast reconstruction. There are few studies comparing biological and synthetic meshes and it is unknown what type of mesh gives the best long-term results. The aim of this study was to compare long-term health-related quality of life (HrQoL) and patient satisfaction in implant-based immediate breast reconstruction with a biological mesh (Surgisis®) with that of patients reconstructed with a synthetic mesh (TIGR ® Matrix Surgical Mesh).Material and methodsBoth cohorts were prospectively included and consecutively operated. Clinical data was collected. HrQoL was evaluated with EuroQoL-5 dimension – 3 levels questionnaire (EQ-5D-3L) and the Hospital Anxiety and Depression Scale (HADS) and the Breast-Q.Results and conclusionSeventy-one patients were operated on in the biological group and 49 in the synthetic group. The response rates were 75 and 84 per cent, respectively. Mean follow-up time was 74 months and 23 months, respectively. There were no statistical differences in satisfaction and quality of life between the two groups. Complications and radiation seem to lead to a lower satisfaction. Our findings could indicate that biological and synthetic meshes give an equal long-term result as regards patients’ perceived quality of life. 相似文献
14.
15.
Dominique Trudel Luminita-Mihaela Avarvarei Michèle Orain Stéphane Turcotte Marie Plante Jean Grégoire Reinhild Kappelhoff David P. Labbé Dimcho Bachvarov Bernard Têtu Christopher M. Overall Isabelle Bairati 《Pathology, research and practice》2019,215(6):152369
Ovarian carcinoma is one of the most lethal malignancies, but only very few prognostic biomarkers are known. The degradome, comprising proteases, protease non-proteolytic homologues and inhibitors, have been involved in the prognosis of many cancer types, including ovarian carcinoma. The prognostic significance of the whole degradome family has not been specifically studied in high-grade serous ovarian cancer. A targeted DNA microarray known as the CLIP-CHIP microarray was used to identify potential prognostic factors in ten high-grade serous ovarian cancer women who had early recurrence (<1.6 years) or late/no recurrence after first line surgery and chemotherapy. In women with early recurrence, we identified seven upregulated genes (TMPRSS4, MASP1/3, SPC18, PSMB1, IGFBP2, CFI – encoding Complement Factor I – and MMP9) and one down-regulated gene (ADAM-10). Using immunohistochemistry, we evaluated the prognostic effect of these 8 candidate genes in an independent cohort of 112 high-grade serous ovarian cancer women. Outcomes were progression, defined according to CA-125 criteria, and death. Multivariate Cox proportional hazard regression models were done to estimate the associations between each protein and each outcome. High ADAM-10 expression (intensity of 2–3) was associated with a lower risk of progression (adjusted hazard ratio (HR): 0.51; 95% confidence interval (CI): 0.29-0.87). High complement factor I expression (intensity 2–3) was associated with a higher risk of progression (adjusted HR: 2.30, 95% CI: 1.17–4.53) and death (adjusted HR: 3.42; 95% CI: 1.72–6.79). Overall, we identified the prognostic value of two proteases, ADAM-10 and complement factor I, for high-grade serous ovarian cancer which could have clinical significance. 相似文献
16.
17.
Lorena Martin-Morales Sara Manzano Maria Rodrigo-Faus Adrian Vicente-Barrueco Victor Lorca Gonzalo Núñez-Moreno Paloma Bragado Almudena Porras Trinidad Caldes Pilar Garre Alvaro Gutierrez-Uzquiza 《International journal of cancer. Journal international du cancer》2023,152(2):283-297
Matrix metalloproteinase-11 (MMP11) is an enzyme with proteolytic activity against matrix and nonmatrix proteins. Although most MMPs are secreted as inactive proenzymes and are later activated extracellularly, MMP11 is activated intracellularly by furin within the constitutive secretory pathway. It is a key factor in physiological tissue remodeling and its alteration may play an important role in the progression of epithelial malignancies and other diseases. TCGA colon and colorectal adenocarcinoma data showed that upregulation of MMP11 expression correlates with tumorigenesis and malignancy. Here, we provide evidence that a germline variant in the MMP11 gene (NM_005940: c.232C>T; p.(Pro78Ser)), identified by whole exome sequencing, can increase the tumorigenic properties of colorectal cancer (CRC) cells. P78S is located in the prodomain region, which is responsible for blocking MMP11's protease activity. This variant was detected in the proband and all the cancer-affected family members analyzed, while it was not detected in healthy relatives. In silico analyses predict that P78S could have an impact on the activation of the enzyme. Furthermore, our in vitro analyses show that the expression of P78S in HCT116 cells increases tumor cell invasion and proliferation. In summary, our results show that this variant could modify the structure of the MMP11 prodomain, producing a premature or uncontrolled activation of the enzyme that may contribute to an early CRC onset in these patients. The study of this gene in other CRC cases will provide further information about its role in CRC development, which might improve patient treatment in the future. 相似文献
18.
19.